These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28621004)

  • 1. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
    Mason SL; Finotello R; Blackwood L
    Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
    Cannon C; Borgatti A; Henson M; Husbands B
    J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
    Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
    Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
    Elliott J
    Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.
    Rassnick KM; Moore AS; Russell DS; Northrup NC; Kristal O; Bailey DB; Flory AB; Kiselow MA; Intile JL
    J Vet Intern Med; 2010; 24(6):1528-31. PubMed ID: 21155191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.
    Kezer KA; Barber LG; Jennings SH
    Vet Comp Oncol; 2018 Mar; 16(1):77-80. PubMed ID: 28419676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.
    Tani H; Kurita S; Miyamoto R; Sawada H; Fujiwara-Igarashi A; Michishita M; Azakami D; Hasegawa D; Tamura K; Bonkobara M
    J Am Anim Hosp Assoc; 2020; 56(3):146. PubMed ID: 32182105
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma.
    Sakuma H; Tani A; Goto-Koshino Y; Ohmi A; Tsujimoto H; Tomiyasu H
    J Vet Med Sci; 2024 Oct; 86(10):1100-1104. PubMed ID: 39198188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
    Yamazaki H; Takagi S; Hosoya K; Okumura M
    Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
    Elliott J; Baines S
    Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Survival Following Treatment of Histiocytic Sarcoma of the Canine Urinary Bladder.
    Patten S; MacKenzie S
    J Am Anim Hosp Assoc; 2022 May; 58(3):156-159. PubMed ID: 35576399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prognostic factors in canine histiocytic sarcoma.
    Dervisis NG; Kiupel M; Qin Q; Cesario L
    Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCNU for the treatment of dogs with histiocytic sarcoma.
    Skorupski KA; Clifford CA; Paoloni MC; Lara-Garcia A; Barber L; Kent MS; LeBlanc AK; Sabhlok A; Mauldin EA; Shofer FS; Couto CG; Sørenmo KU
    J Vet Intern Med; 2007; 21(1):121-6. PubMed ID: 17338159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
    Mastrorilli C; Spangler EA; Christopherson PW; Aubry OA; Newton JC; Smith AN; Kennis RA; Weismann JL; Moore PF
    Vet Clin Pathol; 2012 Sep; 41(3):412-8. PubMed ID: 22747712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models.
    Yamazaki H; Takagi S; Hosoya K; Okumura M
    Res Vet Sci; 2015 Apr; 99():137-44. PubMed ID: 25744435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.
    Moore AS; Taylor DP; Reppas G; Frimberger AE
    Aust Vet J; 2017 Jan; 95(1-2):37-40. PubMed ID: 28124419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histiocytic sarcoma in miniature schnauzers: 30 cases.
    Purzycka K; Peters LM; Elliott J; Lamb CR; Priestnall SL; Hardas A; Johnston CA; Rodriguez-Piza I
    J Small Anim Pract; 2020 Jun; 61(6):338-345. PubMed ID: 32323304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma.
    Klahn SL; Kitchell BE; Dervisis NG
    J Am Vet Med Assoc; 2011 Jul; 239(1):90-6. PubMed ID: 21718201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy.
    Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N
    J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and zoledronate treatment in a dog with hemophagocytic histiocytic sarcoma.
    Soileau AM; Neto RLALT; Jimenez PT; Hamersky J; Smith AA
    Can Vet J; 2023 Dec; 64(12):1103-1108. PubMed ID: 38046421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.